Literature DB >> 10417486

LDL particle size: an important drug target?

I Rajman1, P I Eacho, P J Chowienczyk, J M Ritter.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10417486      PMCID： PMC2014286          DOI： 10.1046/j.1365-2125.1999.00991.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  77 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  A genetic determinant of the phenotypic variance of the molecular weight of low density lipoprotein.

Authors:  W R Fisher; M G Hammond; M C Mengel; G L Warmke
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

3.  Measurement of plasma lipoproteins by electrophoresis on polyacrylamide gel.

Authors:  N Muñiz
Journal:  Clin Chem       Date:  1977-10       Impact factor: 8.327

4.  Troglitazone decreases the proportion of small, dense LDL and increases the resistance of LDL to oxidation in obese subjects.

Authors:  C J Tack; P Smits; P N Demacker; A F Stalenhoef
Journal:  Diabetes Care       Date:  1998-05       Impact factor: 19.112

5.  Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity.

Authors:  N F Galeano; M Al-Haideri; F Keyserman; S C Rumsey; R J Deckelbaum
Journal:  J Lipid Res       Date:  1998-06       Impact factor: 5.922

6.  Polyacrylamide-gel disc-electrophoresis as a screening procedure for serum lipoprotein abnormalities.

Authors:  H K Naito; M Wada; L A Ehrhart; L A Lewis
Journal:  Clin Chem       Date:  1973-02       Impact factor: 8.327

7.  Heterogeneity of serum low density lipoproteins in normal human subjects.

Authors:  M M Shen; R M Krauss; F T Lindgren; T M Forte
Journal:  J Lipid Res       Date:  1981-02       Impact factor: 5.922

8.  A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.

Authors:  K Murakami; K Tobe; T Ide; T Mochizuki; M Ohashi; Y Akanuma; Y Yazaki; T Kadowaki
Journal:  Diabetes       Date:  1998-12       Impact factor: 9.461

9.  Inhibition of oxidation of low density lipoprotein by troglitazone.

Authors:  N Noguchi; H Sakai; Y Kato; J Tsuchiya; Y Yamamoto; E Niki; H Horikoshi; T Kodama
Journal:  Atherosclerosis       Date:  1996-06       Impact factor: 5.162

Review 10.  PPARgamma activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes.

Authors:  G Martin; K Schoonjans; B Staels; J Auwerx
Journal:  Atherosclerosis       Date:  1998-04       Impact factor: 5.162
View more
  20 in total

1.  Usefulness of low-density lipoprotein particle size measurement in cardiovascular disease prevention.

Authors:  Robert D Brook; Mayank Kansal; Robert L Bard; Kim Eagle; Melvyn Rubenfire
Journal:  Clin Cardiol       Date:  2005-11       Impact factor: 2.882

2.  Unconjugated p-cresol activates macrophage macropinocytosis leading to increased LDL uptake.

Authors:  Lee D Chaves; Sham Abyad; Amanda M Honan; Mark A Bryniarski; Daniel I McSkimming; Corrine M Stahura; Steven C Wells; Donna M Ruszaj; Marilyn E Morris; Richard J Quigg; Rabi Yacoub
Journal:  JCI Insight       Date:  2021-06-08

3.  Modular nanotransporters: a multipurpose in vivo working platform for targeted drug delivery.

Authors:  Tatiana A Slastnikova; Andrey A Rosenkranz; Pavel V Gulak; Raymond M Schiffelers; Tatiana N Lupanova; Yuri V Khramtsov; Michael R Zalutsky; Alexander S Sobolev
Journal:  Int J Nanomedicine       Date:  2012-02-02

4.  Oxidized low-density lipoprotein contributes to atherogenesis via co-activation of macrophages and mast cells.

Authors:  Chong Chen; Damir B Khismatullin
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

5.  The immune synapse clears and excludes molecules above a size threshold.

Authors:  Adam N R Cartwright; Jeremy Griggs; Daniel M Davis
Journal:  Nat Commun       Date:  2014-11-19       Impact factor: 14.919

Review 6.  Low density lipoprotein bionanoparticles: From cholesterol transport to delivery of anti-cancer drugs.

Authors:  Gamaleldin I Harisa; Fars K Alanazi
Journal:  Saudi Pharm J       Date:  2013-12-22       Impact factor: 4.330

7.  Small and dense LDL in familial combined hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene.

Authors:  Antonio López-Ruiz; María M Jarabo; María L Martínez-Triguero; Maria Morales-Suárez-Varela; Eva Solá; Celia Bañuls; Marta Casado; Antonio Hernández-Mijares
Journal:  Lipids Health Dis       Date:  2009-03-31       Impact factor: 3.876

8.  Lower Low-Density Lipoprotein Cholesterol Levels Are Associated with Severe Dengue Outcome.

Authors:  Hope H Biswas; Aubree Gordon; Andrea Nuñez; Maria Angeles Perez; Angel Balmaseda; Eva Harris
Journal:  PLoS Negl Trop Dis       Date:  2015-09-03

9.  The LDL-HDL profile determines the risk of atherosclerosis: a mathematical model.

Authors:  Wenrui Hao; Avner Friedman
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

10.  Atherogenic subfractions of lipoproteins in the treatment of metabolic syndrome by physical activity and diet - the RESOLVE trial.

Authors:  Frédéric Dutheil; Guillaume Walther; Robert Chapier; George Mnatzaganian; Bruno Lesourd; Geraldine Naughton; Julien Verney; Anne Fogli; Vincent Sapin; Martine Duclos; Agnès Vinet; Philippe Obert; Daniel Courteix; Gérard Lac
Journal:  Lipids Health Dis       Date:  2014-07-11       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.